Prognostic factors for early-stage CTCL

4 Views
administrator
administrator
08/09/23

Evangelina Papadavid, MD, PhD, National and Kapodistrian University of Athens, Athens, Greece, gives an overview of the management of early-stage cutaneous T-cell lymphoma (CTCL), commenting on the role of prognostic factors, in particular the significance of plaques in early disease, and highlighting the Prospective Cutaneous Lymphoma International Prognostic Indices (PROCLIPI) trial. This interview took place at the EORTC Cutaneous Lymphoma Group 20-21 meeting in Marseille.

Show more

0 Comments Sort By

No comments found

Facebook Comments

Up next